BRAF Inhibitor Resistance in Melanoma: Mechanisms and Alternative Therapeutic Strategies

Melanoma is caused by a variety of somatic mutations, and among these mutations, BRAF mutation occurs most frequently and has routinely been evaluated as a critical diagnostic biomarker in clinical practice. The introduction of targeted agents for BRAF-mutant melanoma has significantly improved over...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Jingqin, Yan, Wangjun, Wang, Chunmeng, Liu, Wanlin, Lin, Xinyi, Zou, Zijian, Sun, Wei, Chen, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Skin Cancer (T Ito, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9596525/
https://www.ncbi.nlm.nih.gov/pubmed/36181568
http://dx.doi.org/10.1007/s11864-022-01006-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9596525/
https://www.ncbi.nlm.nih.gov/pubmed/36181568
http://dx.doi.org/10.1007/s11864-022-01006-7

Ejemplares similares